Glatiramer acetate blocks interleukin-1-dependent nuclear factor-κB activation and RANTES expression in human U-251 MG astroglial cells

Aharoni, 1993, T suppressor hybridomas and interleukin-2-dependent lines induced by copolymer 1 or by spinal cord homogenate down-regulate experimental allergic encephalomyelitis, Eur. J. Immunol., 23, 17, 10.1002/eji.1830230105 Aharoni, 1999, Copolymer 1 acts against the immunodominant epitope 82–100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking, Proc. Natl. Acad. Sci. USA, 96, 634, 10.1073/pnas.96.2.634 Aharoni, 1997, Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis, Proc. Natl. Acad. Sci. USA, 94, 10821, 10.1073/pnas.94.20.10821 Aharoni, 1998, Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1, J. Neuroimmunol., 91, 135, 10.1016/S0165-5728(98)00166-0 Arnon, 1996, The development of Cop 1 (Copaxone), an innovative drug for the treatment of multiple sclerosis: personal reflections, Immunol. Lett., 50, 1, 10.1016/0165-2478(96)02506-0 Ayad, 1998, The heat shock response inhibits RANTES gene expression in cultured human lung epithelium, J. Immunol., 161, 2594, 10.4049/jimmunol.161.5.2594 Barnes, 1996, Induction of RANTES expression by astrocytes and astrocytoma cell lines, J. Neuroimmunol., 71, 207, 10.1016/S0165-5728(96)00154-3 Ben-Nun, 1996, The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease, J. Neurol., 243, S14, 10.1007/BF00873697 Bigner, 1981, Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas, J. Neuropathol. Exp. Neurol., 40, 210, 10.1097/00005072-198105000-00001 Bornstein, 1987, A pilot trial of Cop 1 in exacerbating–remitting multiple sclerosis, N. Engl. J. Med., 317, 408, 10.1056/NEJM198708133170703 Chomczynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction, Anal. Biochem., 162, 156, 10.1016/0003-2697(87)90021-2 Fridkis-Hareli, 1999, Binding of random copolymers of three amino acids to class II MHC molecules, Int. Immunol., 11, 635, 10.1093/intimm/11.5.635 Fridkis-Hareli, 1999, Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules, J. Immunol., 162, 4697, 10.4049/jimmunol.162.8.4697 Fridkis-Hareli, 1994, Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells — specificity and promiscuity, Proc. Natl. Acad. Sci. USA, 91, 4872, 10.1073/pnas.91.11.4872 Hehner, 1998, Sesquiterpene lactones specifically inhibit activation of NF-κB by preventing the degradation of I-κBα and I-κBβ, J. Biol. Chem., 273, 1288, 10.1074/jbc.273.3.1288 Hu, 1999, Inhibition of microglial cell RANTES production by IL-10 and TGF-β, J. Leukoc. Biol., 65, 815, 10.1002/jlb.65.6.815 Janabi, 1998, Induction of human immunodeficiency virus type 1 replication in human glial cells after proinflammatory cytokines stimulation: Effect of IFN-γ, IL-1β, and TNF-α on differentiation and chemokine production in glial cells, Glia, 23, 304, 10.1002/(SICI)1098-1136(199808)23:4<304::AID-GLIA3>3.0.CO;2-2 Johnson, 1995, Copolymer 1 reduces relapse rate and improves disability in relapsing–remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial, Neurology, 45, 1268, 10.1212/WNL.45.7.1268 Johnson, 1998, Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group, Neurology, 50, 701, 10.1212/WNL.50.3.701 Krakauer, 1999, Proinflammatory cytokines: TNF and IL-1 families, chemokines, TGF-β, and others, 775 Li, 1998, Interferon-γ induces cathepsin B expression in a human macrophage-like cell line by increasing both transcription and mRNA stability, Int. J. Mol. Med., 2, 181 Li, 1998, Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human ovarian cancer cells, J. Biol. Chem., 273, 23419, 10.1074/jbc.273.36.23419 Li, 1999, Phorbol ester exposure activates an AP-1-mediated increase in ERCC-1 messenger RNA expression in human ovarian tumor cells, Cell. Mol. Life Sci., 55, 456, 10.1007/s000180050302 Luster, 1998, Chemokines — chemotactic cytokines that mediate inflammation, N. Engl. J. Med., 338, 436, 10.1056/NEJM199802123380706 Mancardi, 1998, Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis, Neurology, 50, 1127, 10.1212/WNL.50.4.1127 Moriuchi, 1997, Nuclear factor-κB potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection, J. Immunol., 158, 3483, 10.4049/jimmunol.158.7.3483 Nelson, 1993, Genomic organization and transcriptional regulation of the RANTES chemokine gene, J. Immunol., 151, 2601, 10.4049/jimmunol.151.5.2601 Noe, 1999, Requirements for measles virus induction of RANTES chemokine in human astrocytoma-derived U373 cells, J. Virol., 73, 3117, 10.1128/JVI.73.4.3117-3124.1999 Pahl, 1996, The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-κB, J. Exp. Med., 183, 1829, 10.1084/jem.183.4.1829 Pan, 1995, Platelet-activating factor stimulates transcription of the heparin-binding epidermal growth factor-like growth factor in monocytes. Correlation with an increased κB binding activity, J. Biol. Chem., 270, 7787, 10.1074/jbc.270.14.7787 Prineas, 1985, The neuropathology of MS, Handb. Clin. Neurol., 3, 213 Prineas, 1978, Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis, Lab. Invest., 38, 409 Raj, 1983, Two levels of regulation of beta-interferon gene expression in human cells, Proc. Natl. Acad. Sci. USA, 80, 3923, 10.1073/pnas.80.13.3923 Read, 1994, NF-κB and IκBα: an inducible regulatory system in endothelial activation, J. Exp. Med., 179, 503, 10.1084/jem.179.2.503 Sambrook, 1989 Schall, 1991, Biology of the RANTES/SIS cytokine family, Cytokine, 3, 165, 10.1016/1043-4666(91)90013-4 Schall, 1990, Selective attraction of monocytes and T lymphocytes of memory phenotype by cytokine RANTES, Nature, 347, 669, 10.1038/347669a0 Schreck, 1992, Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells, J. Exp. Med., 175, 1181, 10.1084/jem.175.5.1181 Siebenlist, 1994, Structure, regulation and function of NF-κB, Ann. Rev. Cell Biol., 10, 405, 10.1146/annurev.cb.10.110194.002201 Simpson, 1998, Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions, J. Neuroimmunol., 84, 238, 10.1016/S0165-5728(97)00208-7 Snedecor, 1967, Statistical methods, 1 Teitelbaum, 1996, Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses, J. Neuroimmunol., 64, 209, 10.1016/0165-5728(95)00180-8 Teitelbaum, 1971, Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide, Eur. J. Immunol., 1, 242, 10.1002/eji.1830010406 Teitelbaum, 1992, Synthetic copolymer 1 inhibits human T-cell lines specific for myelin basic protein, Proc. Natl. Acad. Sci. USA, 89, 137, 10.1073/pnas.89.1.137 Teitelbaum, 1974, Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer, Clin. Immunol. Immunopathol., 3, 256, 10.1016/0090-1229(74)90012-9 Teitelbaum, 1973, Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogen, Eur. J. Immunol., 3, 273, 10.1002/eji.1830030505 Thomas, 1998, Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-κB nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of κBα, J. Immunol., 161, 1007, 10.4049/jimmunol.161.2.1007 Trapp, 1998, Axonal transection in the lesions of multiple sclerosis, N. Engl. J. Med., 338, 278, 10.1056/NEJM199801293380502 Traugott, 1983, Multiple sclerosis. Distribution of T-cell subsets within active chronic lesions, Science, 219, 308, 10.1126/science.6217550 Traugott, 1981, Autoimmune encephalomyelitis: Simultaneous identification of T- and B-cells in the target organ, Science, 214, 1251, 10.1126/science.7029715 Wang, 1999, Suppression of NF-κB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor, Invest. Ophthalmol. Vis. Sci., 40, 477 Weiner, 1999, Oral tolerance with copolymer 1 for the treatment of multiple sclerosis, Proc. Natl. Acad. Sci. USA, 96, 3333, 10.1073/pnas.96.7.3333 Zhang, 1998, AP-2 may contribute to IGF-II overexpression in rhabdomyosarcoma, Oncogene, 17, 1261, 10.1038/sj.onc.1202050 Zoja, 1998, Protein overload stimulates RANTES production by proximal tubular cells depending on NF-κB activation, Kidney Int., 53, 1608, 10.1046/j.1523-1755.1998.00905.x